• ABOUT
        • MISSION/HISTORY
        • DIRECTORS/STAFF
        • SUPPORT
        • INTERNSHIPS
        • FINANCIAL INFORMATION
        • JOBS
        • CONTACT US
  • WASTEWATCHER
  • MEDIA
        • COMMENTARY
        • PRESS RELEASES
        • VIDEOS
  • ISSUES
    • CONGRESSIONAL PIG BOOK
      • EARMARK DATABASE
      • PRIME CUTS
      • ISSUE BRIEFS
      • AGENCY COMMENTS
    • DEFENSE
      • AVIATION & SPACE
      • F-35 JOINT STRIKE FIGHTER
      • PROCUREMENT
    • INNOVATION & TECHNOLOGY POLICY CENTER
      • ANTITRUST
      • ARTIFICIAL INTELLIGENCE
      • BIOPHARMACEUTICALS
      • INTELLECTUAL PROPERTY
      • PRIVACY
      • TECHNOLOGY AND INNOVATION
      • TELECOMMUNICATIONS
    • GENERAL WASTE
      • AGRICULTURE REFORM
      • POSTAL SERVICE
      • TAXES
      • TRANSPORTATION
    • HEALTH AND SCIENCE
      • PRICE CONTROLS
      • GOVERNMENT RUN HEALTHCARE
      • 340B DRUG DISCOUNT PROGRAM
      • PHARMACY BENEFIT MANAGERS
      • TOBACCO HARM REDUCTION
    • STATE ISSUES
  • ITPC
        • ANTITRUST
        • ARTIFICIAL INTELLIGENCE
        • BIOPHARMACEUTICALS
        • INTELLECTUAL PROPERTY
        • PRIVACY
        • TECHNOLOGY AND INNOVATION
        • TELECOMMUNICATIONS
  • CCAGW
DONATE
Facebook X-twitter Icon-instagram-1 Icon-youtube

Biopharmaceuticals

Thomas Schatz

Implementation of Drug Pricing EO Should Protect Innovation and IP

Thomas Schatz April 16, 2025
Thomas Schatz

Biden’s Budget and the SMART Prices Act Will Devastate Drug Development

Thomas Schatz June 24, 2023
Christina Smith

Sen. Elizabeth Warren Wants the Government to Steal IP and Stifle Future Pharmaceutical Innovation

Christina Smith April 27, 2022
Elizabeth Wright

Congress Should Listen to Voters and Reject Drug Price Controls

Elizabeth Wright November 4, 2021
Thomas Schatz

All Nations Must Respect and Protect Intellectual Property Rights

Thomas Schatz April 27, 2021
Elizabeth Wright

Capitalism and Free Markets Will Help Us Through Pandemics

Elizabeth Wright March 25, 2020
« Previous Page1 Page2 Next »
  • ANTITRUST
  • ARTIFICIAL INTELLIGENCE
  • BIOPHARMACEUTICALS
  • INTELLECTUAL PROPERTY
  • PRIVACY
  • TECHNOLOGY AND INNOVATION
  • TELECOMMUNICATIONS
  • ANTITRUST
  • ARTIFICIAL INTELLIGENCE
  • BIOPHARMACEUTICALS
  • INTELLECTUAL PROPERTY
  • PRIVACY
  • TECHNOLOGY AND INNOVATION
  • TELECOMMUNICATIONS


    Citizens Against Government Waste works to eliminate waste, fraud, abuse, and mismanagement in government through research and public education.

    • ABOUT
    • WASTEWATCHER
    • MEDIA CENTER
    • ISSUES
    • ITPC
    • CCAGW
    • 1-800-USA-DEBT ®
    • MEDIA@CAGW.ORG
    • 317 MASSACHUSETTS AVENUE, N.E.
      SUITE 300
      WASHINGTON, D.C. 20002

    © Citizens Against Government Waste